• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Funding roundup: Calypso drums up $6.4 million

Funding roundup: Calypso drums up $6.4 million

January 22, 2011 By MassDevice staff

Funding roundup

Calypso Medical Technologies Inc. raised $6.4 million from what it hopes will be a $7.5 million funding round.

Twenty-seven unnamed investors have participated in the debt and options-based round thus far. The first sale of securites occured on Jan. 6, according to a Securities & Exchange Commission filing.

The Seattle-based company makes a system for targeted prostate cancer radiation therapy. In October, it won 510(k) clearance from the Food and Drug Administration for the Calypso System with "Dynamic Edge Gating Technology," which "automates the response to organ motion that occurs during the delivery of radiation… in order to protect healthy tissue from unintended radiation," according to the company.

Here’s a roundup of the latest dealflow and investment news:

  • EyeSense Attracts QIAGEN as Strategic Investor
    EyeSense AG, a developer of novel ophthalmic self-diagnostic systems for glucose monitoring of diabetes patients, announced that it entered into a strategic partnership with QIAGEN (NSDQ:QGEN). Capitalizing on QIAGEN’s ESE fluorescence-based optical technology and on Eyesense’s glucose sensing technology, the partners intend to develop a new optical measurement technology for blood glucose monitoring in diabetes patients. QIAGEN acquired a minority equity stake in EyeSense and attained royalty rights for future commercialization.
    Read more
  • Century Park Capital Partners Announces the Recapitalization of Cirtec Medical Systems LLC
    Century Park Capital Partners announced that it led the recapitalization of Cirtec Medical Systems LLC along with Charter Oak Equity and the company’s founders. Cirtec is a provider of client focused, comprehensive medical product design, engineering and manufacturing solutions. Cirtec was formed in 2009 from the merger of Circle Medical Devices and Texcel Medical. The company operates out of locations in Los Gatos, Calif. and East Longmeadow, Mass.
    Read more
  • iMedX drums up $2.5 million
    iMedX Inc. raised $2.5 million in equity financing from nine different investors, according to a filing with the Securities & Exchange Commission. The Shelton, Conn.-based company provides medical transcription software and services and is backed by New Canaan, Conn.-based RFE Investment Partners. Last September, the company raised $1.5 million, according to a regulatory filing.
    Read more
  • OrthoCor lands $1.5 million from angels
    OrthoCor Medical Inc., a Minneapolis-based startup that makes an FDA-approved knee brace, has raised $1.5 million from angel investors, reported MedCity News. OrthoCor was one of the first of more than 100 small businesses to register for Minnesota’s angel investment tax credit. About half of the money it raised came from investors who used the credit. OrthoCor, which started out at the University Enterprise Laboratories incubator in St. Paul, received approval from the FDA for its OrthoCor Active Knee System in Dec. 2009.
    Read more

Filed Under: Business/Financial News, News Well, Oncology Tagged With: Calypso Medical Technologies Inc., iMedX Inc.

More recent news

  • Medtronic escapes $106.5M payment in Colibri TAVR patent suit after court overturns jury verdict
  • RadNet closes iCAD acquisition, expands AI breast‑imaging portfolio
  • Hyperfine reports first commercial sales of next-gen AI-powered Swoop
  • Stereotaxis announces $12.5M offering
  • Nuwellis ends clinical trial of its ultrafiltration tech for heart failure

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy